ESEA Valuation
Euroseas Ltd
$
39.190
- Overview
- Forecast
- Valuation
ESEA Relative Valuation
ESEA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ESEA is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for ESEA's competitors is 1.39, providing a benchmark for relative valuation. Euroseas Ltd Corp (ESEA) exhibits a P/S ratio of 1.20, which is -13.36% above the industry average. Given its robust revenue growth of 8.66%, this premium appears unsustainable.
People Also Watch
CATX
Perspective Therapeutics Inc
2.615
USD
-7.60%
CIA
Citizens Inc
3.880
USD
-0.26%
AMRN
Amarin Corporation PLC
11.110
USD
0.00%
TBI
TrueBlue Inc
5.765
USD
+2.22%
BDMD
Baird Medical Investment Holdings Ltd
5.050
USD
0.00%
FLYX
Flyexclusive Inc
2.800
USD
-3.45%
DOGZ
Dogness International Corp
23.600
USD
+3.15%
FBLA
FB Bancorp Inc
11.453
USD
-0.32%
CRDF
Cardiff Oncology Inc
3.005
USD
-2.12%
FUND
Sprott Focus Trust Inc
7.200
USD
-0.41%
FAQ
Is Euroseas Ltd (ESEA) currently overvalued or undervalued?
Euroseas Ltd (ESEA) is now in the Fair zone, suggesting that its current forward PE ratio of 2.69 is considered Fairly compared with the five-year average of 1.51. The fair price of Euroseas Ltd (ESEA) is between 19.74 to 47.83 according to relative valuation methord.
What is Euroseas Ltd (ESEA) fair value?
How does ESEA's valuation metrics compare to the industry average?
What is the current P/B ratio for Euroseas Ltd (ESEA) as of May 21 2025?
What is the current FCF Yield for Euroseas Ltd (ESEA) as of May 21 2025?
What is the current Forward P/E ratio for Euroseas Ltd (ESEA) as of May 21 2025?